Stay updated with breaking news from Ocular Presentation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX – Get Rating) saw a significant decline in short interest in the month of April. As of April 15th, there was short interest totalling 80,600 shares, a decline of 15.0% from the March 31st total of 94,800 shares. Currently, 4.7% of the shares of the company are short sold. Based on […]
Encinitas, California--(Newsfile Corp. - April 27, 2023) - Kiora Pharmaceuticals (NASDAQ: KPRX) presented preliminary results from an ongoing clinical trial showing its investigational drug, KIO-301,
In a second presentation, Kiora shared additional positive results for its KIO-100 platform in the treatment of autoimmune uveitis. Encinitas, California--(Newsfile Corp. - April 26, 2023) - Kiora Pharmaceuticals
Encinitas, California--(Newsfile Corp. - April 21, 2023) - Kiora Pharmaceuticals (NASDAQ: KPRX) has appointed Mark Pennesi, M.D., Ph.D., the Kenneth C. Swan Endowed Professor in Ophthalmology and Molecular
Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX – Get Rating) dropped 2.4% on Monday . The stock traded as low as $3.93 and last traded at $4.05. Approximately 66,594 shares traded hands during trading, a decline of 95% from the average daily volume of 1,300,305 shares. The stock had previously closed at $4.15. Wall Street Analyst Weigh In […]